Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quinolone therapy in intensive care unit settings

T R Beam1

  • 1Buffalo Veterans Administration Medical Center, State University of New York at Buffalo 14215.

New Horizons (Baltimore, Md.)
|May 1, 1993
PubMed
Summary

Fluoroquinolones like norfloxacin, ciprofloxacin, and ofloxacin are effective against Gram-negative bacteria in ICUs. They are recommended for treating specific infections but not for selective decontamination protocols.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Panel discussion: morning session.

Bulletin of the New York Academy of Medicine·2009
Same author

Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group.

The Journal of infectious diseases·1996
Same author

In-vitro activity of trospectromycin against gram-positive cocci.

The Journal of antimicrobial chemotherapy·1995
Same author

Anti-infective drugs in the prevention and treatment of sepsis syndrome.

Critical care nursing clinics of North America·1994
Same author

Susceptibility of bacteraemic isolates of gram-positive cocci to daptomycin and other antimicrobial agents.

The Journal of antimicrobial chemotherapy·1994
Same author

European guidelines for anti-infective drug products. Introduction.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1993

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Intensive care unit (ICU) patients are susceptible to Gram-negative bacterial infections.
  • Fluoroquinolones are a class of antimicrobials with activity against these pathogens.

Observation:

  • Norfloxacin, ciprofloxacin, and ofloxacin are key fluoroquinolones with unique pharmacokinetic profiles.
  • Ciprofloxacin and ofloxacin offer intravenous administration options.
  • These agents exhibit potent activity against Gram-negative aerobic bacteria.

Findings:

  • Fluoroquinolones are not recommended for selective decontamination protocols.
  • Endorsed for empiric therapy of suspected Gram-negative infections, guided by local susceptibility data.
  • Recommended for treating documented infections due to favorable distribution, low toxicity, and rapid bactericidal action.

Implications:

  • Optimizing fluoroquinolone use in ICUs requires consideration of specific infection types and bacterial resistance patterns.
  • Intravenous formulations of ciprofloxacin and ofloxacin enhance treatment flexibility in critically ill patients.
  • Evidence supports fluoroquinolones as valuable agents for managing serious Gram-negative bacterial infections in the ICU setting.

Related Experiment Videos